Companies / BOC Sciences / Gantenerumab
BOC Sciences

Gantenerumab | BOC Sciences

Gantenerumab is a human monoclonal antibody targeting amyloid-_ (A_). Gantenerumab was developed for the treatment of early symptomatic and asymptomatic Alzheimer's disease (AD).

Reviews


No reviews yet

ABOUT THE COMPANY

BOC Sciences specializes in small molecule synthesis, biosynthesis, purification, and characterization. It provides a wide range of research chemicals and biochemicals, including inhibitors, building blocks, carbohydrates, nucleosides, nucleotides, GMP Products, impurities and metabolites, APIs, natural compounds, ADCs, stem cell molecules and chiral compounds.